Greenwich LifeSciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
78.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.18
|
0.00
|
0.18
|
100.00%
|
|
2022-12-31
|
-0.19
|
0.00
|
0.19
|
100.00%
|
|
2022-09-30
|
-0.19
|
-0.18
|
0.01
|
5.26%
|
|
2022-06-30
|
-0.19
|
-0.06
|
0.13
|
68.42%
|
|
2022-03-31
|
-0.19
|
-0.15
|
0.04
|
21.05%
|
|
2021-12-31
|
-0.07
|
-0.18
|
-0.11
|
-157.14%
|
|
2021-09-30
|
-0.06
|
-0.07
|
-0.01
|
-16.67%
|
|
2021-06-30
|
-0.06
|
-0.06
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.39
|
|
2021-12-31
|
-0.36
|
|
2020-12-31
|
-0.20
|
|
2019-12-31
|
-14.25
|
|
2018-12-31
|
-0.73
|